Mantell Associates recently appointed Anjan Selz as Managing Director at Polpharma Biologics Switzerland AG. Anjan is a seasoned leader with over 20 years of experience in the Pharma and Biosimilars space. His focus lies on leadership through empowerment, creating an environment where individuals and teams can excel and deliver their best ever performance.
Polpharma Biologics is an international biotechnology company with integrated operations in the European Union, developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production preparing drugs for future commercial partnerships with global pharmaceutical players. The company’s expertise is in the development and manufacturing of medicines based on microbial and mammalian expression systems. With its cell line development center in Netherlands and two centers of development and manufacturing in Poland, Polpharma Biologics creates growth and development opportunities for biotechnology specialists.
Company website – https://polpharmabiologics.com/
To find out more about Polpharma Biologics, contact Tom Bryan on +44 (0)20 3854 7700 or tom.bryan@mantellassociates.com.